Gottlieb: 'Enormous Investment' Needed For New Flu Vaccine Technology

A fundamental change in manufacturing would be needed for the United States to shift from “antiquated” egg-based flu vaccines to newer technologies like cell-based vaccines and recombinant DNA technology, which could pave the way toward a universal vaccine, government experts told lawmakers March 8. But investing in continuous manufacturing can help usher along this shift, FDA Commissioner Scott Gottlieb argued. Heads of the Centers for Disease Control and Prevention, Biomedical Advanced Research and Development Authority, National Institutes of Health and...